WhatsApp Logo Subscribe
For News Alert

News

Pfizer profits drop on lower Covid-19 product sales

By AFP

May 1, 2024 06:52 PM


Twitter Share Facebook Share WhatsApp Share

Pfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and implements previously announced cost cuts.

Much lower sales of Covid-19 vaccine Comirnaty and therapeutic Paxlovid accounted for a 20 percent drop in first-quarter revenues to $14.9 billion compared with the year-ago period.

Profits were $3.1 billion, down 44 percent.

The drugmaker pointed to increased sales of oncology products, in part driven by the acquisition of Seagen, which was completed in December.

Other products with significant growth included Vyndaquel, which is used to treat nerve disease; Eliquis, which treats blood clots; and Prevnar, a vaccine for pneumonia.

"I am very pleased by the strong 11 percent operational revenues growth of our non-Covid products in the first quarter," said Chief Financial Officer David Denton.

"We continue to progress our cost realignment program and remain on track to deliver on our targeted goal by the end of the year."

Pfizer said it will deliver "at least" $4 billion in savings by the end of 2024.

The company, which raised its earnings per share projection, has maintained a shareholder dividend. However, it plans no share repurchases in 2024 in favor of pumping funds back into research and development to support the drug pipeline.

Shares of Pfizer rose 1.3 percent in pre-market trading.


AFP


Most Read

  1. Two senior lawyers shot dead by Elite Force jawan in Attock court Two senior lawyers shot dead by Elite Force jawan in Attock court
  2. Bajwa-Khan bond 2.0: After Urvashi Rautela, Sonam Bajwa becomes Naseem Shah’s fan Bajwa-Khan bond 2.0: After Urvashi Rautela, Sonam Bajwa becomes Naseem Shah’s fan
  3. Sindh CM unveils ambitious Rs3.056 trillion budget for FY 2024-25 Sindh CM unveils ambitious Rs3.056 trillion budget for FY 2024-25
  4. PML-N MNA flees after coming face to face with Imran Khan PML-N MNA flees after coming face to face with Imran Khan
  5. LUMS secures third position at United Asians Debating Championship LUMS secures third position at United Asians Debating Championship
  6. Police arrest principal and MS Sahiwal hospital after children’s death in blaze Police arrest principal and MS Sahiwal hospital after children’s death in blaze

Opinion

  1. An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!
    An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!

    By Sudheendra Kulkarni

  2. Premier Shehbaz and Chinese model
    Premier Shehbaz and Chinese model

    By Naveed Aman Khan

  3. Modi's myth broken, yet in power
    Modi's myth broken, yet in power

    By Naveed Aman Khan

  4. Xi, Shehbaz and CPEC phase - 2
    Xi, Shehbaz and CPEC phase - 2

    By Naveed Aman Khan

  5. Pakistan's UNSC Triumph: A New Era
    Pakistan's UNSC Triumph: A New Era

    By Dr Asif Channer

  6. Shehbaz, Deng, Xi and transformation
    Shehbaz, Deng, Xi and transformation

    By Naveed Aman Khan